4Fonteinen SRL
1.0 FTEThe score of 4Fonteinen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1807 % Total assets +23 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
4Fonteinen's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 13 Aug 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 19 Jul 2023
- Year ended 31 Dec 2021filed on 03 Jul 2022
4Fonteinen's financial analysis
- Solvency9.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of 4Fonteinen
4Fonteinen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0760.403.586
- VAT number
- BE0760403586
- Peppol
- Registered · 0208:0760403586 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Dec 2020
- Registered office
- 1830 Machelen (Brab.)
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
4Fonteinen (SRL) has been based in Machelen (Brab.) since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 48,858 € and equity of 103,151 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 9.2%, below the median of its sector (44.2%).
Companies similar to 4Fonteinen
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Viaene Retail sale of pharmaceutical products Deerlijk · balance sheet €1.12m
- Apoteek Rooyackers Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet €1.12m
- Meta Invest & Consult Retail sale of pharmaceutical products Antwerp · balance sheet €1.11m
- Bio-Homeopharma Retail sale of pharmaceutical products Antwerp · balance sheet €1.11m
- Pharmacie DU Petit Courcelles Retail sale of pharmaceutical products Courcelles · balance sheet €1.64m
- Beirnaert Farma Retail sale of pharmaceutical products Destelbergen · balance sheet €1.13m
- LB Farma Retail sale of pharmaceutical products Kasterlee · balance sheet €1.13m
- Van der Vennet Apotheek Retail sale of pharmaceutical products Ghent · balance sheet €1.14m
Frequently asked questions about 4Fonteinen
What is the revenue of 4Fonteinen?
4Fonteinen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of 4Fonteinen?
In Belgium, the VAT number is the company number prefixed with BE: BE0760403586 for 4Fonteinen, if the company is VAT-registered. Its company number (CBE) is 0760.403.586.
Where is the registered office of 4Fonteinen?
According to the CBE register, the registered office of 4Fonteinen is in 1830 Machelen (Brab.).
What is the equity of 4Fonteinen?
At the close of the 2025 financial year, the equity of 4Fonteinen amounts to 103,151 €, a solvency of 9.2% of total assets.
How many people work at 4Fonteinen?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages 4Fonteinen?
The register lists 3 active mandates at 4Fonteinen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of 4Fonteinen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →